93 related articles for article (PubMed ID: 9744304)
1. VCAM (IGSF) adhesion molecule expression in breast carcinomas detected by automated and quantitative immunocytochemical assays.
Charpin C; Garcia S; Andrac L; Horschowski N; Choux R; Lavaut MN
Hum Pathol; 1998 Sep; 29(9):896-903. PubMed ID: 9744304
[TBL] [Abstract][Full Text] [Related]
2. VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
Charpin C; Garcia S; Bergeret D; Andrac L; Horschowski N; Choux R; Lavaut MN
Br J Cancer; 1998 Jun; 77(12):2274-80. PubMed ID: 9649145
[TBL] [Abstract][Full Text] [Related]
3. ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays.
Charpin C; Bergeret D; Garcia S; Andrac L; Martini F; Horschowski N; Choux R; Lavaut MN
Int J Oncol; 1998 May; 12(5):1041-8. PubMed ID: 9538126
[TBL] [Abstract][Full Text] [Related]
4. Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.
Charpin C; Garcia S; Bouvier C; Devictor B; Andrac L; Lavaut MN; Allasia C
Br J Cancer; 1997; 76(3):340-6. PubMed ID: 9252201
[TBL] [Abstract][Full Text] [Related]
5. CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors.
Charpin C; Devictor B; Bergeret D; Andrac L; Boulat J; Horschowski N; Lavaut MN; Piana L
Am J Clin Pathol; 1995 Apr; 103(4):443-8. PubMed ID: 7726141
[TBL] [Abstract][Full Text] [Related]
6. VLA(3)/integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
Garcia S; Bergeret D; Martini F; Andrac L; Horschowski N; Choux R; Levaut M; Charpin C
Int J Oncol; 1997 Oct; 11(4):849-56. PubMed ID: 21528284
[TBL] [Abstract][Full Text] [Related]
7. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators.
Charpin C; Vielh P; Duffaud F; Devictor B; Andrac L; Lavaut MN; Allasia C; Horschowski N; Piana L
J Natl Cancer Inst; 1994 Oct; 86(20):1539-45. PubMed ID: 7932810
[TBL] [Abstract][Full Text] [Related]
8. bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlation with 10-year follow-up.
Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
J Clin Oncol; 1998 Jun; 16(6):2025-31. PubMed ID: 9626199
[TBL] [Abstract][Full Text] [Related]
9. CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas: correlation with patient follow-up.
Charpin C; Garcia S; Bouvier C; Martini F; Andrac L; Bonnier P; Lavaut MN; Allasia C
Am J Clin Pathol; 1997 May; 107(5):534-41. PubMed ID: 9128265
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival.
Charpin C; Garcia S; Bouvier C; Martini F; Lavaut M; Allasia C; Bonnier P; Andrac L
J Clin Pathol; 1997 Jul; 50(7):586-90. PubMed ID: 9306940
[TBL] [Abstract][Full Text] [Related]
11. Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas.
Charpin C; Garcia S; Bouvier C; Devictor B; Andrac L; Choux R; Lavaut MN; Allasia C
Hum Pathol; 1997 Mar; 28(3):289-96. PubMed ID: 9042792
[TBL] [Abstract][Full Text] [Related]
12. Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays.
Charpin C; Dales JP; Garcia S; Carpentier S; Djemli A; Andrac L; Lavaut MN; Allasia C; Bonnier P
Clin Cancer Res; 2004 Sep; 10(17):5815-9. PubMed ID: 15355911
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin quantitative immunocytochemical assays in breast carcinomas.
Charpin C; Garcia S; Bouvier C; Devictor B; Andrac L; Choux R; Lavaut M
J Pathol; 1997 Mar; 181(3):294-300. PubMed ID: 9155715
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors.
Charpin C; Devictor B; Bonnier P; Andrac L; Lavaut MN; Allasia C; Piana L
J Pathol; 1993 Aug; 170(4):463-70. PubMed ID: 8410496
[TBL] [Abstract][Full Text] [Related]
15. p53 quantitative immunocytochemical analysis in breast carcinomas.
Charpin C; DeVictor B; Andrac L; Amabile J; Bergeret D; LaVaut MN; Allasia C; Piana L
Hum Pathol; 1995 Feb; 26(2):159-66. PubMed ID: 7860046
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
[TBL] [Abstract][Full Text] [Related]
17. CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients.
Dales JP; Garcia S; Bonnier P; Duffaud F; Andrac-Meyer L; Ramuz O; Lavaut MN; Allasia C; Charpin C
Am J Clin Pathol; 2003 Mar; 119(3):374-80. PubMed ID: 12645339
[TBL] [Abstract][Full Text] [Related]
18. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma.
O'Hanlon DM; Fitzsimons H; Lynch J; Tormey S; Malone C; Given HF
Eur J Cancer; 2002 Nov; 38(17):2252-7. PubMed ID: 12441261
[TBL] [Abstract][Full Text] [Related]
19. Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas.
Charpin C; Bouvier C; Garcia S; Martini F; Andrac L; Lavaut MN; Allasia C
Int J Cancer; 1997 Aug; 74(4):416-20. PubMed ID: 9291431
[TBL] [Abstract][Full Text] [Related]
20. Quantitative imaging of ps2 immunocytochemical assays in breast carcinomas.
Charpin C; Devictor B; Bonnier P; Andrac L; Boulat J; Lavaut M; Allasia C; Piana L
Int J Oncol; 1993 Mar; 2(3):443-8. PubMed ID: 21573575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
